Apyx Medical Corp (APYX) Cash and securities
- Total cash · latest quarter (USD): Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities. Period ending 2026-06-30..
- Cash per share · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2026-06-30..
Cash and securities
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total cash · latest quarter (USD) | (m) | Cash and cash equivalents plus current marketable securities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Cash per share · latest quarter | (m) | Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash and equivalents | 27.62M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Marketable Securities, Current |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total cash | Cash per share | Cash and equivalents (USD) | Short-term securities (USD) | Quarter-end shares (shares) |
|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $27.62M | (m) | (m) |
| 2026-03-31 | (m) | (m) | $31.14M | (m) | (m) |
| 2025-12-31 | (m) | (m) | $31.74M | (m) | (m) |
| 2025-09-30 | (m) | (m) | $25.14M | (m) | (m) |
| 2025-06-30 | (m) | (m) | $29.30M | (m) | (m) |
| 2025-03-31 | (m) | (m) | $31.01M | (m) | (m) |
| 2024-12-31 | (m) | (m) | $31.74M | (m) | (m) |
| 2024-09-30 | (m) | (m) | $28.01M | (m) | (m) |
| 2024-06-30 | (m) | (m) | $32.68M | (m) | (m) |
| 2024-03-31 | (m) | (m) | $37.28M | (m) | (m) |
| 2023-12-31 | (m) | (m) | $43.65M | (m) | (m) |
| 2023-09-30 | (m) | (m) | $22.13M | (m) | (m) |
| 2023-06-30 | (m) | (m) | $18.48M | (m) | (m) |
| 2023-03-31 | (m) | (m) | $16.25M | (m) | (m) |
| 2022-12-31 | (m) | (m) | $10.19M | (m) | (m) |
| 2022-09-30 | (m) | (m) | $14.83M | (m) | (m) |
| 2022-06-30 | (m) | (m) | $20.06M | (m) | (m) |
| 2022-03-31 | (m) | (m) | $26.23M | (m) | (m) |
| 2021-12-31 | (m) | (m) | $30.87M | (m) | (m) |
| 2021-09-30 | (m) | (m) | $30.90M | (m) | (m) |
| 2021-06-30 | (m) | (m) | $34.67M | (m) | (m) |
| 2021-03-31 | (m) | (m) | $39.54M | (m) | (m) |
| 2020-12-31 | $81.58M | (m) | $41.91M | $39.66M | (m) |
| 2020-09-30 | (m) | (m) | $43.54M | (m) | (m) |
| 2020-06-30 | (m) | (m) | $46.16M | (m) | (m) |
| 2020-03-31 | (m) | (m) | $51.38M | (m) | (m) |
| 2019-12-31 | $115.39M | (m) | $58.81M | $56.58M | (m) |
| 2019-09-30 | $123.27M | (m) | $62.27M | $61.00M | (m) |
| 2019-06-30 | (m) | (m) | $67.36M | (m) | (m) |
| 2019-03-31 | (m) | (m) | $32.41M | (m) | (m) |
| 2018-12-31 | (m) | (m) | $16.47M | (m) | (m) |
| 2018-09-30 | (m) | (m) | $40.66M | (m) | (m) |
| 2018-06-30 | (m) | (m) | $7.88M | (m) | (m) |
| 2018-03-31 | (m) | (m) | $8.70M | (m) | (m) |
| 2017-12-31 | (m) | (m) | $9.95M | (m) | (m) |
| 2017-09-30 | (m) | (m) | $9.41M | (m) | (m) |
| 2017-06-30 | (m) | (m) | $10.29M | (m) | (m) |
| 2017-03-31 | (m) | (m) | $11.51M | (m) | (m) |
| 2016-12-31 | (m) | (m) | $14.46M | (m) | (m) |
| 2016-09-30 | (m) | (m) | $9.33M | (m) | (m) |
| 2016-06-30 | (m) | (m) | $9.32M | (m) | (m) |
| 2016-03-31 | (m) | (m) | $9.46M | (m) | (m) |
| 2015-12-31 | (m) | (m) | $11.80M | (m) | (m) |
| 2015-09-30 | (m) | (m) | $13.20M | (m) | (m) |
| 2015-06-30 | (m) | (m) | $14.09M | (m) | (m) |
| 2015-03-31 | (m) | (m) | $15.40M | (m) | (m) |
| 2014-12-31 | (m) | (m) | $5.73M | (m) | (m) |
| 2014-09-30 | (m) | (m) | $6.13M | (m) | (m) |
| 2014-06-30 | (m) | (m) | $5.58M | (m) | (m) |
| 2014-03-31 | (m) | (m) | $5.82M | (m) | (m) |
| 2013-12-31 | (m) | (m) | $7.92M | (m) | (m) |
| 2013-09-30 | (m) | (m) | $2.50M | (m) | (m) |
| 2013-06-30 | (m) | (m) | $2.56M | (m) | (m) |
| 2013-03-31 | (m) | (m) | $3.76M | (m) | (m) |
| 2012-12-31 | (m) | (m) | $4.16M | (m) | (m) |
| 2012-09-30 | (m) | (m) | $4.49M | (m) | (m) |
| 2012-06-30 | (m) | (m) | $4.98M | (m) | (m) |
| 2012-03-31 | (m) | (m) | $4.12M | (m) | (m) |
| 2011-12-31 | (m) | (m) | $4.88M | (m) | (m) |
| 2011-09-30 | (m) | (m) | $5.41M | (m) | (m) |
| 2011-06-30 | (m) | (m) | $5.71M | (m) | (m) |
| 2011-03-31 | (m) | (m) | $4.45M | (m) | (m) |
| 2010-12-31 | (m) | (m) | $3.83M | (m) | (m) |
| 2010-09-30 | (m) | (m) | $2.65M | (m) | (m) |
| 2010-06-30 | (m) | (m) | $3.37M | (m) | (m) |
| 2009-12-31 | (m) | (m) | $2.15M | (m) | (m) |
| 2008-12-31 | (m) | (m) | $2.56M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |